Announced Mon, 15 Jun · 15:02 IST
Promoters confirm no encumbrance on shares for FY26
Compliance View source PDF
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.0%1-day move
₹1530.00
prior close
₹1503.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.2+0.8—-1.0+0.5+2.6+2.3+9.8+7.8+9.0+13.0——
Up moveDown movePending
AI summary
Poly Medicure's promoters, along with persons acting in concert, have submitted a disclosure under SEBI Takeover Regulations confirming they did not create any encumbrance (pledge, lien, or charge) on their shares during the financial year ended March 31, 2026. The disclosure lists 21 promoter-group entities and individuals, including Managing Director Himanshu Baid and other family members and related LLPs/companies.
Likely market impact
Routine annual compliance filing with no material impact on shareholders; confirms promoter holdings remain unencumbered.